SEBIO 2014 Board of Directors

Officers:
Chair: Becky Kaufman, King & Spalding LLP
Vice-Chair and Secretary: Sue Washer, AGTC
Treasurer: Mark Baxter, Ernst & Young
Ex Officio: Aaron Davidson, H.I.G. BioVentures

Executive Committee:
Brian Adams, Arbor Pharmaceuticals, Inc.
Mark Baxter, Ernst & Young
Aaron Davidson, H.I.G. BioVentures
David Day, University of Florida, Office of Technology Licensing
Tim Gupton, Hughes Pittman & Gupton, LLP
Mike Gutch, MedImmune Ventures
Frank Hunt, PNP Therapeutics, Inc.
Becky Kaufman, King & Spalding LLP
Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Doug Reed, Hatteras Venture Partners
Ken Tindall, North Carolina Biotechnology Center
Sue Washer, AGTC
Dave Winwood, UAB Research Foundation

Directors:
Russell Allen, Georgia Bio
Ali Behbahani, NEA
William Brooke, Harbert Venture Partners
Gerry Brunk, Lumira Capital
Tom Callaway, Life Science Partner
Suzanne Cantando, Southeast BIO
Kathy Carr, Tall Oaks Capital
Mark Crowell, University of Virginia
Jeff Gallagher, Virginia Bio
Steve Hall, Lilly Ventures
Mara Huntington, Square 1 Bank
Rick Kent, Intersouth Partners
Garheng Kong, Sofinnova Ventures
Dan Myers, Alimera Sciences, Inc.
Kathy Nugent, BioAlabama
Rose Ritts, Duke University, Office of Licensing & Ventures
Larry Robbins, Wyrick Robbins Yates & Ponton, LLP
Wayne Roper, SCBIO
Seth Rudnick, Canaan Partners
Todd Sherer, Emory University, Office of Technology Transfer
Susan Shows, Georgia Research Alliance
Samuel Taylor, NCBIO
Abby Trotter, Life Science Tennessee
Geeta Vemuri, Baxter Healthcare Corporation
Richard West
Miriam Wilson, Council for Entrepreneurial Development (CED)
Bill Wofford, Hutchison Law Group
Ford Worthy, Pappas Ventures
Karen Zederej, AxoGen, Inc.